Skip to main content

Elon Musk’s brain implant company Neuralink says it has US approval to begin trials in people

Elon Musk's brain-implant company Neuralink on Thursday said it had received a green light from the U.S. Food and Drug Administration (FDA) to kickstart its first-in-human clinical study, a critical milestone after earlier struggles to gain approval.

Media Miss by the Right

See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below.

Learn more about this data

Left 28%

Center 44%

Right 29%

Bias Distribution

Click to see headlines

Far
Left

+0

Untracked Bias

219 other sources covering this story

Total News Sources

219

Leaning Left

38

Center

60

Leaning Right

40

Last Updated

1 year ago

Bias Distribution Powered by Ground News